Download MendeleyRebamipide and Derivatives are Potent, Selective Inhibitors of Histidine Phosphatase Activity of the Suppressor of T Cell Receptor Signaling Proteins.
Aziz, F., Reddy, K., Fernandez Vega, V., Dey, R., Hicks, K.A., Rao, S., Jordan, L.O., Smith, E., Shumate, J., Scampavia, L., Carpino, N., Spicer, T.P., French, J.B.(2024) J Med Chem 67: 1949-1960
- PubMed: 38252624
- DOI: https://doi.org/10.1021/acs.jmedchem.3c01763
- Primary Citation of Related Structures:
8U5M, 8U7E - PubMed Abstract:
The suppressor of T cell receptor signaling (Sts) proteins are negative regulators of immune signaling. Genetic inactivation of these proteins leads to significant resistance to infection. From a 590,000 compound high-throughput screen, we identified the 2-( 1H )-quinolinone derivative, rebamipide, as a putative inhibitor of Sts phosphatase activity. Rebamipide, and a small library of derivatives, are competitive, selective inhibitors of Sts-1 with IC 50 values from low to submicromolar. SAR analysis indicates that the quinolinone, the acid, and the amide moieties are all essential for activity. A crystal structure confirmed the SAR and reveals key interactions between this class of compound and the protein. Although rebamipide has poor cell permeability, we demonstrated that a liposomal preparation can inactivate the phosphatase activity of Sts-1 in cells. These studies demonstrate that Sts-1 enzyme activity can be pharmacologically inactivated and provide foundational tools and insights for the development of immune-enhancing therapies that target the Sts proteins.
Organizational Affiliation:
The Hormel Institute, University of Minnesota, Austin, Minnesota 55912, United States.
